Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2

被引：0
|
作者：
Chen Li
Lu Lu
Bing Feng
Kai Zhang
Siqi Han
Daorong Hou
Longbang Chen
Xiaoyuan Chu
Rui Wang
机构：
[1] Medical School of Nanjing University,Department of Medical Oncology, Jinling Hospital
[2] Animal Core Facility of Nanjing Medical University,undefined
来源：
Scientific Reports | / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Editor's Note: this Article has been retracted; the Retraction Note is available at https://doi.org/10.1038/s41598-023-32251-x
引用
收藏
相关论文
共 50 条
  • [1] RETRACTED ARTICLE: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2
    Chen Li
    Lu Lu
    Bing Feng
    Kai Zhang
    Siqi Han
    Daorong Hou
    Longbang Chen
    Xiaoyuan Chu
    Rui Wang
    Scientific Reports, 7
  • [2] RETRACTION: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2 (Retraction of Vol 7, art no 4637, 2017)
    Li, Chen
    Lu, Lu
    Feng, Bing
    Zhang, Kai
    Han, Siqi
    Hou, Daorong
    Chen, Longbang
    Chu, Xiaoyuan
    Wang, Rui
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] RETRACTED: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2 (Retracted article. See vol. 13, 2023)
    Li, Chen
    Lu, Lu
    Feng, Bing
    Zhang, Kai
    Han, Siqi
    Hou, Daorong
    Chen, Longbang
    Chu, Xiaoyuan
    Wang, Rui
    SCIENTIFIC REPORTS, 2017, 7
  • [4] LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1
    Shang, Muhe
    Wang, Xianghu
    Zhang, Ying
    Gao, Zhikui
    Wang, Tian
    Liu, Ran
    ONCOTARGETS AND THERAPY, 2018, 11 : 639 - 649
  • [5] miR-145 modulates epithelial-mesenchymal transition and invasion by targeting ZEB2 in non-small cell lung cancer cell lines
    Liu, Qun
    Chen, Jianhui
    Wang, Baolan
    Zheng, Yulong
    Wan, Yufeng
    Wang, Yi
    Zhou, Liyang
    Liu, Shu
    Li, Gang
    Yan, Yi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8409 - 8418
  • [6] LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1
    Ma, Jianli
    Yang, Yue
    Huo, Desheng
    Wang, Zanyu
    Zhai, Xiaoyu
    Chen, Jing
    Sun, Huixin
    An, Weiwei
    Jie, Jing
    Yang, Pengxiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (03) : 614 - 620
  • [7] lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
    Eades, Gabriel
    Wolfson, Benjamin
    Zhang, Yongshu
    Li, Qinglin
    Yao, Yuan
    Zhou, Qun
    MOLECULAR CANCER RESEARCH, 2015, 13 (02) : 330 - 338
  • [8] LincRNA-ROR/miR-145/ZEB2 regulates liver fibrosis by modulating HERC5-mediated p53 ISGylation
    Shen, Jie
    Wang, Zhu
    Liu, Mei
    Zhu, Yu-Jie
    Zheng, Ling
    Wang, Li-Li
    Cheng, Jie-Ling
    Liu, Tong-Tong
    Zhang, Guo-Dong
    Yang, Tian-Yu
    Wang, Xiao
    Zhang, Lei
    FASEB JOURNAL, 2023, 37 (06):
  • [9] miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2
    Qiu, Gongcai
    Lin, Yujia
    Zhang, Haogang
    Wu, Dequan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (03) : 315 - 321
  • [10] MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2
    Zhu, Wei
    Luo, Xuewen
    Fu, Hui
    Liu, Lijian
    Sun, Pingliang
    Wang, Zhiguang
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (10)
12345